Form 4 for PFE Pfizer
Accepted 2021-09-02 00:00:00 ET · period of report 2021-08-31 · accession 0001225208-21-011947 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-02 | 2021-08-31 | PFE | MALIK AAMIR | EVP | A - Grant | $0.00 | +43.4K | 43.8K | +11,607% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-31 | A | A | 43,412 | $0.00 | 43,786 | D | — | — | (F1) The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. |